GSK new drug application for Myelofibrosis treatment Momelotinib accepted by USFDA Ruchika Sharma19 Aug 2022 2:00 PM ISTNew Delhi: GSK plc has announced that the US Food and Drug Administration (USFDA) has accepted the New Drug Application (NDA) for momelotinib, a...
Oral pill improves care of patients with bone marrow cancer: Study Dr. Kamal Kant Kohli11 Jun 2022 9:15 AM ISTCHICAGO AND SAN ANTONIO: Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a...
GSK to acquire Sierra Oncology for USD 1.9 billion Ruchika Sharma17 April 2022 11:00 AM ISTUnder the terms of the agreement, the acquisition will be effected through a one-step merger in which the shares of Sierra Oncology outstanding will...
USFDA accelerates approval of CTI BioPharma's pacritinib MD Bureau1 March 2022 12:44 PM ISTVONJO is a novel oral kinase inhibitor. VONJO is the first approved therapy that specifically addresses the needs of patients with cytopenic...
Researchers attempt new treatment approach for blood cancer Hina Zahid25 Jun 2020 8:31 AM IST(Boston)--In an effort to improve the survival of patients with myeloproliferative neoplasms, a type of leukemia, researchers inhibited a specific...
